SUMMARYPathogenic animal trypanosomes affecting livestock have represented a major constraint to
agricultural development in Africa for centuries, and their negative economic impact is
increasing in South America and Asia. Chemotherapy and chemoprophylaxis represent the main
means of control. However, research into new trypanocides has remained inadequate for
decades, leading to a situation where the few compounds available are losing efficacy due
to the emergence of drug-resistant parasites. In this review, we provide a comprehensive
overview of the current options available for the treatment and prophylaxis of the animal
trypanosomiases, with a special focus on the problem of resistance. The key issues
surrounding the main economically important animal trypanosome species and the diseases
they cause are also presented. As new investment becomes available to develop improved
tools to control the animal trypanosomiases, we stress that efforts should be directed
towards a better understanding of the biology of the relevant parasite species and
strains, to identify new drug targets and interrogate resistance mechanisms.